Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer

Eur J Med Chem. 2020 Dec 1:207:112695. doi: 10.1016/j.ejmech.2020.112695. Epub 2020 Aug 18.

Abstract

A family of heterofunctional Schiff base carbosilane metallodendrons with [Ru(η5-C5H5)(PTA)Cl] (PTA = 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decane) at the focal point and dimethylamino groups on the periphery are described. The new systems have proved their ability to interact with biological molecules such as Human Serum Albumin (HSA) without affecting its secondary structure and erythrocytes membranes, causing haemolysis in a dose and generation dependent way. The combination of two active functional groups in one single dendritic platform has shown a cooperative effect in the viability of HeLa and PC-3 cells, with the second generation derivative standing out as the most promising with the lowest IC50. Experiments focused on advanced prostate cancer have shown an antimetastasic activity for those metallodendrons, hindering the adhesion of cells in one of the main targets of metastasis, bones, and inhibiting cell migration. Finally, the second generation metallodendron with one single metal centre and four dimethylamino groups on the dendritic wedge, was selected for an ex vivo experiment in nude mice with advanced prostate cancer inhibiting the tumour growth in a 40% compared to control mice.

Keywords: Carbosilane; Dendron; Ex vivo; Organometallic; Prostate cancer; Ruthenium; Schiff base.

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Dendrimers / chemistry
  • Dendrimers / pharmacology
  • Dendrimers / therapeutic use
  • HeLa Cells
  • Humans
  • Male
  • Mice
  • Mice, Nude
  • Organometallic Compounds / chemistry
  • Organometallic Compounds / pharmacology
  • Organometallic Compounds / therapeutic use
  • PC-3 Cells
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Ruthenium / chemistry*
  • Ruthenium / pharmacology*
  • Ruthenium / therapeutic use
  • Silanes / chemistry*
  • Silanes / pharmacology*
  • Silanes / therapeutic use

Substances

  • Antineoplastic Agents
  • Dendrimers
  • Organometallic Compounds
  • Silanes
  • carbosilane
  • Ruthenium